| CRISPR Medicine | This is an overview of all our articles
Epicrispr Biotechnologies has completed enrolment and dose escalation in the first-in-human trial of EPI-321, an epigenetic CRISPR-based therapy for...
Preliminary Phase 1 data from Fate Therapeutics indicate that its off-the-shelf CAR T-cell therapy, FT819, can induce early clinical responses in...
Researchers at Ghent University have engineered virus-like particles decorated with anti-CD4 nanobodies to deliver CRISPR-Cas machinery selectively...
Sangamo Therapeutics researchers have engineered the serine integrase Bxb1 to insert large DNA sequences at chosen genomic sites without requiring...
Researchers have used CRISPR base editing to identify a previously unknown regulatory mechanism in the WNT–β-catenin signaling pathway, revealing a...
Researchers in Denmark have used CRISPR-Cas9 genome editing to generate T cells expressing a naturally occurring T-cell receptor (TCR) that recognises...
A perspective article in Nature Reviews Bioengineering outlines how CRISPR-based RNA silencing could be integrated into ex vivo machine perfusion of...
Some of the best links we picked up around the internet
